I have just sent another email to Patrick Rooney to confirm that the deal with the yet to be named multi-billion dollar NYSE company has already been executed as touted in this press release:
while POSC's position as the leading Cardio PET imaging manufacturer makes the company attractive to investors, its revolutionary Pharm-Assist® automated radiopharmaceutical distribution device is what has attracted the attention of not only one multi-billion dollar NYSE company which has already inked a yet-to-be announced deal with Positron, but other publicly traded, big cap companies as well.
I've also requested a breakout of projected sales targets by PET, Pharm-Assist, service, etc.
I will post his response upon receipt. If you have additional questions, please email Mr. Rooney and post them on this board.